Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,STC1,Stanniocalcin-1,Inverse variance weighted,11,1.17 [0.92-1.49],0.206807929771558
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TCN2,Transcobalamin-2,Inverse variance weighted,66,1.02 [0.95-1.09],0.661458841449795
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,24,0.97 [0.82-1.14],0.679861506887878
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.94 [0.74-1.20],0.642354085404099
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CALCA,Calcitonin,Inverse variance weighted,17,1.22 [0.94-1.60],0.136331359954564
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AGRP,Agouti-related protein,Inverse variance weighted,20,1.03 [0.84-1.26],0.771368812425562
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFRC,Transferrin receptor protein 1,Inverse variance weighted,48,1.03 [0.92-1.15],0.602830193664477
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,22,0.93 [0.76-1.13],0.471917808172266
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.99 [0.88-1.10],0.797349415867073
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,16,0.88 [0.72-1.08],0.222803370150266
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,0.96 [0.85-1.10],0.570310062012062
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,1.10 [0.62-1.98],0.740378158609827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,0.87 [0.74-1.01],0.0716563233130169
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPP1,Osteopontin,Inverse variance weighted,19,1.08 [0.84-1.39],0.5272890590268
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,15,1.05 [0.90-1.23],0.534663478877055
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,0.79 [0.55-1.14],0.209962550532929
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.04 [0.81-1.33],0.755259978982005
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL27,C-C motif chemokine 27,Inverse variance weighted,12,1.04 [0.82-1.32],0.756603854912454
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.95 [0.82-1.11],0.516627791313768
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.03 [0.85-1.26],0.759598790208818
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.14 [0.92-1.41],0.222485619711181
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,0.98 [0.80-1.19],0.806660414254155
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,1.10 [0.93-1.30],0.260313769015421
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,9,1.05 [0.75-1.48],0.764875014065646
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,17,1.00 [0.85-1.18],0.999944994160764
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL19,Interleukin-19,Inverse variance weighted,21,1.05 [0.93-1.17],0.441831739286156
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,1.03 [0.97-1.10],0.34858851471763
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,28,0.96 [0.83-1.12],0.597208004719469
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.92 [0.67-1.27],0.627896383322525
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.03 [0.88-1.22],0.683176628001045
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.07 [0.68-1.68],0.761183632229903
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ITGAV,Integrin alpha-V,Inverse variance weighted,14,0.99 [0.73-1.35],0.944556118839818
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.15 [0.97-1.36],0.0990912630388079
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,6,0.84 [0.62-1.15],0.28392929036036
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FCRLB,Fc receptor-like B,Inverse variance weighted,65,1.09 [1.02-1.17],0.0162632470782606
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,49,1.05 [0.98-1.13],0.191447067832294
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,47,1.04 [0.97-1.12],0.293883990493106
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,27,0.98 [0.88-1.10],0.779421249555574
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,19,1.07 [0.85-1.34],0.561813551282687
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FSTL1,Follistatin-related protein 1,Inverse variance weighted,15,1.00 [0.79-1.27],0.968346768184173
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CFD,Complement factor D,Inverse variance weighted,12,0.99 [0.83-1.17],0.868227950658141
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NFASC,Neurofascin,Inverse variance weighted,19,1.09 [0.95-1.24],0.206945303570154
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,52,0.96 [0.84-1.10],0.545876637799741
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,24,1.19 [0.98-1.46],0.0846637074197192
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,1.04 [0.95-1.13],0.399170950591923
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CST3,Cystatin-C,Inverse variance weighted,13,1.00 [0.83-1.20],0.969483477484209
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.08 [1.02-1.14],0.004120100020404
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,14,0.88 [0.74-1.04],0.129101598530759
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FBLN2,Fibulin-2,Inverse variance weighted,17,0.96 [0.83-1.11],0.581603358488198
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.00 [0.78-1.28],0.998233357933562
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.95 [0.85-1.06],0.35726021012179
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,19,1.01 [0.88-1.16],0.880676734391374
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,40,0.97 [0.87-1.07],0.54022052862242
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,10,1.06 [0.85-1.32],0.585379498430288
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DRAXIN,Draxin,Inverse variance weighted,38,1.02 [0.92-1.12],0.748588573447608
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.00 [0.87-1.15],0.974454942691045
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.02 [0.86-1.20],0.829999937505168
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.94 [0.66-1.36],0.757280401275861
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANXA5,Annexin A5,Inverse variance weighted,2,0.96 [0.57-1.60],0.862933179940442
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TCOF1,Treacle protein,Inverse variance weighted,2,1.57 [0.68-3.63],0.291796183889924
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,0.87 [0.70-1.09],0.218334125347925
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,1.03 [0.91-1.17],0.604007021613099
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,8,0.98 [0.83-1.17],0.842144284625945
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.09 [0.91-1.31],0.362276683876417
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEMA3F,Semaphorin-3F,Inverse variance weighted,46,1.06 [0.90-1.24],0.493847617700613
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL21,C-C motif chemokine 21,Inverse variance weighted,19,1.07 [0.85-1.34],0.553007338939695
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,C7,Complement component C7,Inverse variance weighted,60,1.00 [0.94-1.06],0.916976957330971
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,0.99 [0.90-1.08],0.749685140096833
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,2.00 [0.88-4.53],0.0980777953314541
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.99 [0.75-1.30],0.929188354511048
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,12,1.03 [0.84-1.26],0.76498726290293
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAYN,Layilin,Inverse variance weighted,23,1.03 [0.89-1.20],0.681610179423665
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,1.19 [0.72-1.95],0.499400008206827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,7,0.81 [0.62-1.05],0.116724132473035
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.13 [0.30-4.30],0.858763722493153
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MILR1,Allergin-1,Inverse variance weighted,43,0.99 [0.92-1.06],0.746771597076189
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,18,1.11 [0.89-1.40],0.360996740235379
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPL,N-acetylneuraminate lyase,Inverse variance weighted,16,0.96 [0.80-1.15],0.624940773093795
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,52,0.96 [0.86-1.07],0.42752744295984
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.04 [0.91-1.19],0.54906827401819
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCN3,CCN family member 3,Inverse variance weighted,20,1.15 [0.98-1.35],0.0799631705032037
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.96 [0.54-1.73],0.900826173862176
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,37,0.97 [0.89-1.05],0.437226088887186
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CWC15,Spliceosome-associated protein CWC15 homolog,Wald ratio,1,1.53 [0.57-4.13],0.398160391562348
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,16,0.97 [0.80-1.16],0.72469742555538
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,32,0.91 [0.82-1.02],0.115525649390995
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.10 [0.76-1.60],0.6193564773759
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.00 [0.88-1.13],0.95028985502071
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,34,1.00 [0.90-1.10],0.987800660600058
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.94 [0.73-1.22],0.652509623891645
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,44,1.04 [0.96-1.12],0.382854440070167
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.13 [1.02-1.25],0.0223802968912936
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TPR,Nucleoprotein TPR,Wald ratio,1,1.25 [0.53-2.94],0.616060076705969
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BCAM,Basal cell adhesion molecule,Inverse variance weighted,34,1.07 [0.95-1.19],0.275703768381418
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,75,1.00 [0.95-1.06],0.983490235439338
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,9,0.99 [0.71-1.39],0.956176622995943
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,16,0.95 [0.81-1.12],0.533596869230083
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.94 [0.67-1.33],0.731310077543455
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,1.00 [0.86-1.15],0.957495109579225
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCN5,CCN family member 5,Inverse variance weighted,12,0.88 [0.73-1.06],0.19465744449395
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.08 [0.97-1.21],0.17490878808786
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,1.11 [0.87-1.42],0.39984427267732
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,31,1.03 [0.97-1.09],0.351833024392977
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,11,0.98 [0.79-1.23],0.892024199561352
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,0.99 [0.91-1.07],0.751571127305493
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PCDH17,Protocadherin-17,Inverse variance weighted,47,1.02 [0.93-1.11],0.723165417271646
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.92 [0.85-0.99],0.0318588543603162
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.01 [0.72-1.41],0.966104856398138
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.12 [0.88-1.42],0.357870561296757
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL20,C-C motif chemokine 20,Inverse variance weighted,8,1.05 [0.76-1.45],0.761925529734914
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.09 [0.88-1.35],0.416325827858279
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP3,Stromelysin-1,Inverse variance weighted,35,0.92 [0.82-1.04],0.203982040669868
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,28,1.01 [0.86-1.18],0.938021251584249
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,30,0.95 [0.86-1.04],0.265508075232521
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,4,0.85 [0.57-1.26],0.409843949032546
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,1.23 [1.02-1.47],0.0279386519619275
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.08 [0.92-1.25],0.342964125631046
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,0.96 [0.88-1.04],0.275742471112312
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,2.38 [1.22-4.63],0.01083339283447
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.05 [0.75-1.48],0.759561643236564
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,0.56 [0.42-0.74],7.1045941423191e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,32,0.96 [0.85-1.08],0.450340516319643
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,15,1.00 [0.80-1.25],0.991047013829241
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REN,Renin,Inverse variance weighted,12,1.02 [0.85-1.24],0.805051543148531
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ASAH1,Acid ceramidase,Inverse variance weighted,21,0.98 [0.90-1.08],0.705437319671056
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDH1,Cadherin-1,Inverse variance weighted,17,0.98 [0.79-1.22],0.873211439992136
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,19,0.96 [0.84-1.10],0.563716934799201
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,14,1.12 [0.90-1.40],0.301787765625124
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,21,1.17 [0.94-1.46],0.161179747614214
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.17 [1.02-1.35],0.0275363297678571
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.87-1.08],0.602089773099874
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TMSB10,Thymosin beta-10,Wald ratio,1,0.53 [0.21-1.35],0.184803580205195
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,45,0.92 [0.85-1.00],0.0498477316185535
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CPM,Carboxypeptidase M,Inverse variance weighted,23,0.99 [0.81-1.21],0.91752722687285
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,12,0.98 [0.90-1.07],0.657681415369607
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADA2,Adenosine deaminase 2,Inverse variance weighted,18,1.03 [0.83-1.29],0.769466779400958
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MENT,Protein MENT,Inverse variance weighted,30,1.18 [1.03-1.36],0.016858490688456
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAM3D,Protein FAM3D,Inverse variance weighted,56,0.98 [0.90-1.07],0.732360441178096
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MUC13,Mucin-13,Inverse variance weighted,13,1.00 [0.80-1.24],0.999610100860844
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.97 [0.74-1.28],0.837277422116041
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,1.25 [1.06-1.47],0.0090566372541761
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLSTN2,Calsyntenin-2,Inverse variance weighted,38,0.98 [0.89-1.08],0.69675681060547
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,30,1.02 [0.86-1.19],0.854333076762829
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLXNB2,Plexin-B2,Inverse variance weighted,37,1.06 [0.99-1.12],0.0734467946570506
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,1.06 [0.86-1.31],0.57335181742628
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.41 [0.70-2.85],0.33305573101994
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.08 [0.99-1.18],0.100989232155326
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,9,0.98 [0.63-1.51],0.927545313937885
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,0.97 [0.85-1.10],0.650991643999979
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NECTIN4,Nectin-4,Inverse variance weighted,12,0.93 [0.79-1.10],0.377367688076369
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,0.91 [0.78-1.05],0.191908139904053
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK4,Kallikrein-4,Inverse variance weighted,20,0.91 [0.81-1.03],0.129470355958394
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,46,0.98 [0.85-1.13],0.766219811620525
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP10,Stromelysin-2,Inverse variance weighted,30,0.94 [0.83-1.07],0.361670603204152
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,24,0.91 [0.80-1.04],0.183036584817792
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.27 [1.10-1.47],0.0008865178687572
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,22,0.90 [0.74-1.10],0.318210135947838
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.10 [0.46-2.59],0.831584144041965
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,1.00 [0.91-1.10],0.997468466394299
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,0.91 [0.74-1.11],0.328608379713436
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,0.96 [0.86-1.08],0.538876323506052
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.69-1.26],0.660187365301434
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,14,0.89 [0.70-1.14],0.369069034510216
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,27,0.98 [0.86-1.13],0.820131937781985
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,0.94 [0.50-1.77],0.840025726136262
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BCAN,Brevican core protein,Inverse variance weighted,15,0.98 [0.81-1.18],0.819966612053602
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.20 [0.83-1.75],0.329092491324555
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.97 [0.88-1.07],0.549749708704381
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,28,1.05 [0.94-1.18],0.368227223470541
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.92 [0.81-1.04],0.163259229298846
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,0.82 [0.65-1.04],0.101695059323781
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,10,1.01 [0.75-1.36],0.969529885223558
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,3,1.14 [0.45-2.86],0.784953459977176
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGMN,Legumain,Inverse variance weighted,32,1.03 [0.88-1.20],0.715398874275652
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADM,Pro-adrenomedullin,Inverse variance weighted,4,1.12 [0.86-1.46],0.393201289540536
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.81 [0.70-0.94],0.0066696214027459
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.91 [0.77-1.07],0.253419785320018
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.05 [0.95-1.16],0.332946574183865
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,17,1.08 [0.81-1.44],0.601537241050764
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Inverse variance weighted,2,2.06 [0.95-4.44],0.0657113953691431
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.82 [0.64-1.05],0.117376423773536
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RBP7,Retinoid-binding protein 7,Inverse variance weighted,15,1.02 [0.87-1.20],0.782043371802292
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,XCL1,Lymphotactin,Inverse variance weighted,47,1.02 [0.93-1.12],0.693570596069476
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL22,C-C motif chemokine 22,Inverse variance weighted,13,1.22 [0.92-1.62],0.17498246151455
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DBI,Acyl-CoA-binding protein,Inverse variance weighted,10,0.83 [0.67-1.03],0.0969682859986255
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD83,CD83 antigen,Inverse variance weighted,19,0.96 [0.78-1.18],0.706060172676856
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SHISA5,Protein shisa-5,Inverse variance weighted,16,0.75 [0.53-1.06],0.106854867043457
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,0.95 [0.83-1.09],0.443433892169118
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,4,0.89 [0.53-1.49],0.647901687437444
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.11 [0.88-1.39],0.394664312927789
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,7,0.89 [0.60-1.33],0.569457941024838
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,0.78 [0.57-1.06],0.109543113680265
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.01 [0.72-1.42],0.944109901826012
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MSMB,Beta-microseminoprotein,Inverse variance weighted,92,1.00 [0.95-1.06],0.894851512952495
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.03 [0.64-1.66],0.894558236562016
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RBP2,Retinol-binding protein 2,Inverse variance weighted,6,1.80 [1.04-3.10],0.0342738916310696
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DPT,Dermatopontin,Inverse variance weighted,26,0.89 [0.77-1.03],0.125491353580715
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,0.98 [0.91-1.06],0.669743658363298
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,24,1.03 [0.91-1.18],0.619393413149015
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LMNB2,Lamin-B2,Inverse variance weighted,9,0.99 [0.67-1.46],0.94034449290812
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.08 [0.93-1.27],0.320872886727827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,XG,Glycoprotein Xg,Inverse variance weighted,2,1.11 [0.19-6.47],0.905978180731288
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CYTL1,Cytokine-like protein 1,Inverse variance weighted,10,1.01 [0.94-1.08],0.871316214884834
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSV,Cathepsin L2,Inverse variance weighted,34,1.04 [0.90-1.19],0.625422683370812
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.16 [0.92-1.46],0.209549504305304
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RTBDN,Retbindin,Inverse variance weighted,5,0.89 [0.64-1.24],0.503947661131724
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,12,0.77 [0.58-1.01],0.0605612447705109
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.08 [0.86-1.37],0.502843391285436
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PYY,Peptide YY,Inverse variance weighted,16,1.07 [0.90-1.27],0.447710383816294
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,1.13 [0.70-1.83],0.62508274190395
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.15 [0.77-1.71],0.506156343689036
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,1.05 [0.89-1.24],0.550508075230878
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,1.02 [0.84-1.24],0.856015508534894
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP8,Neutrophil collagenase,Inverse variance weighted,25,1.03 [0.93-1.14],0.574287101322619
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.98 [0.88-1.09],0.713164735396329
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FOLR2,Folate receptor beta,Inverse variance weighted,16,0.98 [0.71-1.37],0.924567018499686
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ROBO1,Roundabout homolog 1,Inverse variance weighted,25,0.86 [0.70-1.05],0.134145508666858
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.88 [0.64-1.21],0.428025850841582
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,37,0.97 [0.90-1.06],0.516343435850359
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.27 [1.00-1.63],0.0546153969012606
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DSG2,Desmoglein-2,Inverse variance weighted,22,1.01 [0.86-1.19],0.917800054313856
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.27 [0.91-1.76],0.156061919906752
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MME,Neprilysin,Inverse variance weighted,49,1.03 [0.92-1.15],0.581369949780277
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.04 [0.92-1.17],0.523942192614667
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,3,1.11 [0.40-3.07],0.833936805390014
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,40,1.14 [1.03-1.27],0.0097534068450796
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CX3CL1,Fractalkine,Inverse variance weighted,23,1.22 [1.01-1.48],0.0369653301568282
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.63 [0.25-1.55],0.312199875718102
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.02 [0.93-1.11],0.710403968006205
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AREG,Amphiregulin,Inverse variance weighted,7,1.14 [0.82-1.58],0.427160743892548
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.08 [0.96-1.22],0.185737363845348
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.83 [0.49-1.43],0.506533287119524
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,14,1.10 [0.90-1.35],0.329615945431567
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,0.93 [0.78-1.11],0.451712570131833
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP7,Matrilysin,Inverse variance weighted,15,1.01 [0.88-1.16],0.861735573304206
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.83 [0.67-1.03],0.0879251329067559
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNC,Tenascin,Inverse variance weighted,57,1.02 [0.94-1.12],0.614452474848259
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDH3,Cadherin-3,Inverse variance weighted,12,0.93 [0.70-1.24],0.637434128045535
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.47 [0.58-3.75],0.420633696532664
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.13 [0.95-1.33],0.157007910042347
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPON2,Spondin-2,Inverse variance weighted,8,0.88 [0.72-1.08],0.232891786443644
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS3,Galectin-3,Inverse variance weighted,42,0.97 [0.88-1.07],0.539065360749998
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,THBD,Thrombomodulin,Inverse variance weighted,16,1.15 [0.97-1.37],0.0972021350076941
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,28,0.95 [0.78-1.16],0.623071629913379
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,28,1.09 [0.94-1.26],0.272561223280824
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PKD2,Polycystin-2,Inverse variance weighted,5,0.55 [0.31-0.98],0.0423249922051402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.99 [0.73-1.36],0.974132892170472
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,8,0.79 [0.60-1.03],0.0781161839464841
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,11,0.99 [0.84-1.17],0.948783135291909
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,25,1.05 [0.97-1.14],0.257115018261838
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,F9,Coagulation factor IX,Inverse variance weighted,3,1.20 [0.61-2.39],0.59468915392736
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,50,1.02 [0.90-1.17],0.729125973416754
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,1.01 [0.94-1.10],0.737889260502456
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.01 [0.77-1.34],0.929178455250921
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.97 [0.84-1.11],0.65717035518466
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RETN,Resistin,Inverse variance weighted,28,0.93 [0.84-1.03],0.157727514264092
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.01 [0.78-1.32],0.917530661182809
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,0.99 [0.72-1.34],0.931078445445497
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,THBS2,Thrombospondin-2,Inverse variance weighted,33,1.01 [0.92-1.12],0.806044034424303
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD276,CD276 antigen,Inverse variance weighted,47,1.00 [0.92-1.08],0.939327554241856
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,1.06 [0.94-1.18],0.341738143127353
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,0.91 [0.82-1.00],0.0538731744340076
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,13,0.88 [0.76-1.01],0.0713807949174108
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,27,1.14 [0.97-1.34],0.118263961041399
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,0.83 [0.73-0.95],0.007807933425698
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,23,1.06 [0.88-1.29],0.526511583068744
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,15,1.01 [0.93-1.10],0.773750184349648
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,10,0.81 [0.53-1.25],0.344305797505172
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ELN,Elastin,Inverse variance weighted,12,1.29 [0.88-1.90],0.185642600052297
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRH,Corticoliberin,Inverse variance weighted,62,1.05 [0.96-1.16],0.250715789857407
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.98 [0.90-1.07],0.623615239210081
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.88 [0.40-1.91],0.742317718501294
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,0.98 [0.90-1.08],0.721743389338269
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,66,1.04 [0.95-1.14],0.402910534423568
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BRK1,Protein BRICK1,Inverse variance weighted,10,1.03 [0.71-1.49],0.870128689235102
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,POF1B,Protein POF1B,Inverse variance weighted,4,0.84 [0.41-1.71],0.626591839151842
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.93 [0.79-1.10],0.390378866076449
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.26 [0.93-1.72],0.135512846544468
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS9,Galectin-9,Inverse variance weighted,39,0.99 [0.87-1.13],0.904803190053847
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.07 [0.93-1.23],0.369232683805023
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,1.10 [0.69-1.75],0.694606354649521
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,42,1.05 [0.96-1.14],0.301675567985773
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,24,1.01 [0.85-1.18],0.948697207339061
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,40,1.00 [0.87-1.15],0.976423977042185
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VWC2,Brorin,Inverse variance weighted,35,0.99 [0.89-1.11],0.897752426139506
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,0.97 [0.92-1.01],0.144200122919445
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.17 [0.71-1.92],0.533794562307293
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,1.00 [0.92-1.08],0.954383661088613
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.01 [0.83-1.22],0.929107610025936
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIGLEC1,Sialoadhesin,Inverse variance weighted,31,1.00 [0.88-1.14],0.96954610991009
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PALM2,Paralemmin-2,Inverse variance weighted,9,1.02 [0.79-1.32],0.858707322273368
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.07 [0.95-1.20],0.283244875262539
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VIT,Vitrin,Inverse variance weighted,38,1.01 [0.94-1.09],0.765673417156438
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.76 [1.09-2.85],0.0219115204629856
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,0.94 [0.83-1.06],0.310339184201267
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,1.16 [0.83-1.64],0.385446317851369
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,1.01 [0.87-1.18],0.8557637486615
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,0.99 [0.89-1.11],0.867301629142578
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.98 [0.75-1.29],0.904819348170346
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.89 [0.75-1.06],0.195694346720536
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,0.92 [0.82-1.04],0.195878201038179
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MSLN,Mesothelin,Inverse variance weighted,36,0.97 [0.89-1.05],0.43445543551384
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OCLN,Occludin,Inverse variance weighted,3,0.71 [0.36-1.39],0.320387886550698
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FDX1,"Adrenodoxin, mitochondrial",Inverse variance weighted,2,1.14 [0.51-2.55],0.743959380416124
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,6,1.25 [1.01-1.55],0.0374282812069406
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,2,0.91 [0.37-2.26],0.840359866021925
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COLEC12,Collectin-12,Inverse variance weighted,13,0.88 [0.67-1.17],0.380728233778676
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,0.92 [0.71-1.19],0.516044029787867
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NRP2,Neuropilin-2,Inverse variance weighted,26,0.76 [0.63-0.91],0.0024135657723888
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,1.01 [0.90-1.12],0.924558605270611
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,15,1.02 [0.81-1.30],0.844609092886373
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,4,1.30 [0.93-1.82],0.120169682206032
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,0.99 [0.91-1.07],0.709260902773899
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL6,Interleukin-6,Inverse variance weighted,6,0.80 [0.63-1.01],0.0601386370520201
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SLAMF7,SLAM family member 7,Inverse variance weighted,40,1.06 [0.97-1.16],0.192820436719974
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,8,1.04 [0.75-1.46],0.80236272297956
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,27,0.96 [0.89-1.04],0.301237647677448
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.00 [0.90-1.12],0.9397627614798
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.98 [0.73-1.32],0.880958963344406
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,23,0.97 [0.83-1.13],0.675221604830424
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,1.08 [0.92-1.27],0.363248888777402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,0.95 [0.78-1.16],0.620783156776913
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.86 [0.46-1.58],0.625138200601863
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.03 [0.75-1.41],0.860524020405942
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,37,1.00 [0.88-1.13],0.986897606045364
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,28,1.04 [0.96-1.11],0.335843841956314
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,0.82 [0.70-0.95],0.0105011612648414
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.87 [0.65-1.17],0.355619279925936
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.04 [0.91-1.19],0.540501147423901
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,33,1.07 [0.93-1.23],0.368926139278495
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COCH,Cochlin,Inverse variance weighted,37,1.02 [0.94-1.12],0.590946758189206
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NRP1,Neuropilin-1,Inverse variance weighted,26,1.04 [0.91-1.19],0.606589917440314
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,0.95 [0.79-1.15],0.624455468730767
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MFGE8,Lactadherin,Inverse variance weighted,26,0.92 [0.80-1.05],0.222524768953004
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HJV,Hemojuvelin,Inverse variance weighted,3,1.00 [0.75-1.34],0.976096662770567
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,6,1.07 [0.74-1.55],0.721361181403005
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,24,1.00 [0.83-1.20],0.987464645683335
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,28,0.94 [0.82-1.08],0.373177657110276
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,1.00 [0.93-1.07],0.9258174845987
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.80 [0.64-0.99],0.0377125342340622
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,78,0.96 [0.88-1.03],0.264256812936626
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,4,1.00 [0.70-1.42],0.990319713505767
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.74 [0.63-4.79],0.283892315477204
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,1.02 [0.72-1.43],0.924055268690781
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NECTIN2,Nectin-2,Inverse variance weighted,8,1.02 [0.87-1.19],0.816634959385614
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AOC3,Membrane primary amine oxidase,Inverse variance weighted,35,0.97 [0.88-1.06],0.479678837508111
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.95 [0.77-1.18],0.65234575162885
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.00 [0.84-1.19],0.997946141388609
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,1.22 [0.96-1.56],0.104214013452785
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,UMOD,Uromodulin,Inverse variance weighted,62,1.05 [0.99-1.12],0.122262623038208
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.85 [0.56-1.30],0.446604808943134
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.79 [0.56-1.12],0.182891601087873
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,50,1.07 [0.98-1.16],0.111517767937127
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,36,1.12 [0.99-1.27],0.0711005003312696
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,10,0.99 [0.67-1.47],0.966338972509904
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.02 [0.74-1.43],0.88696172135227
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,24,0.91 [0.82-1.00],0.0615068947607002
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,0.93 [0.78-1.10],0.4014681560294
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.70 [0.35-1.41],0.321299506478542
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,14,0.93 [0.82-1.06],0.275782863164842
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,15,0.97 [0.83-1.13],0.668987256845935
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,0.99 [0.91-1.07],0.720943660114771
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,1.09 [0.22-5.45],0.916535632154807
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.06 [0.95-1.17],0.300415856258611
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK11,Kallikrein-11,Inverse variance weighted,19,1.09 [0.98-1.21],0.130254517248115
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,54,1.05 [0.91-1.21],0.478334047608225
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC3B,Tetranectin,Inverse variance weighted,9,0.97 [0.76-1.23],0.773091348626616
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTN,Pleiotrophin,Inverse variance weighted,7,1.23 [0.78-1.94],0.37988411454553
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PPL,Periplakin,Inverse variance weighted,2,0.88 [0.43-1.81],0.732069810147275
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MVK,Mevalonate kinase,Inverse variance weighted,3,0.84 [0.47-1.50],0.563078808655749
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHGB,Secretogranin-1,Inverse variance weighted,33,0.94 [0.86-1.03],0.160952506605453
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.91 [0.70-1.18],0.471351343841161
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,STAB2,Stabilin-2,Inverse variance weighted,32,0.95 [0.86-1.06],0.352009908319786
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GCG,Pro-glucagon,Inverse variance weighted,2,0.50 [0.15-1.73],0.275598641461557
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,16,1.08 [0.95-1.23],0.248264712039543
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,75,0.93 [0.87-1.00],0.0384575373412826
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.66 [0.36-1.21],0.18156045210704
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AMBP,Protein AMBP,Inverse variance weighted,5,1.03 [0.63-1.70],0.896386732264402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.00 [0.38-2.63],0.992790436680215
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.85 [0.73-0.98],0.0278941858568547
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSD,Cathepsin D,Inverse variance weighted,24,1.16 [0.97-1.38],0.102959057297349
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHGA,Chromogranin-A,Inverse variance weighted,8,0.99 [0.79-1.24],0.930339343780517
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,22,1.04 [0.93-1.16],0.523047067217425
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPOCK1,Testican-1,Inverse variance weighted,31,1.07 [0.90-1.27],0.446626312567075
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,15,1.01 [0.73-1.39],0.946488373016133
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1.16 [0.75-1.81],0.500385958012642
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,1.09 [0.74-1.60],0.674203745491013
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL4,C-C motif chemokine 4,Inverse variance weighted,38,1.01 [0.91-1.11],0.884640358148575
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,0.86 [0.74-0.99],0.0343196002015331
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCG2,Secretogranin-2,Inverse variance weighted,3,0.78 [0.43-1.41],0.418508679733671
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,14,1.00 [0.82-1.22],0.985941787547362
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.63 [0.37-1.07],0.0872342176992798
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,41,1.01 [0.94-1.08],0.807279600885264
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,STC2,Stanniocalcin-2,Inverse variance weighted,12,0.93 [0.69-1.26],0.650625282681342
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,0.99 [0.76-1.29],0.927550136282218
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.04 [0.67-1.60],0.877060700037633
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD70,CD70 antigen,Inverse variance weighted,39,1.07 [0.99-1.16],0.106475660970819
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EGFR,Epidermal growth factor receptor,Inverse variance weighted,15,1.09 [0.81-1.46],0.589169917987532
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,44,1.04 [0.96-1.12],0.391770434597479
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.00 [0.77-1.31],0.998500347420493
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,0.92 [0.79-1.06],0.237911790122957
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DCN,Decorin,Inverse variance weighted,3,1.06 [0.48-2.31],0.891542297439949
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,1.07 [0.98-1.17],0.136314486292556
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.92-1.06],0.700859581833173
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GUCA2A,Guanylin,Inverse variance weighted,16,0.90 [0.74-1.10],0.309918413183451
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.07 [0.81-1.42],0.620083616212453
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,0.89 [0.74-1.07],0.205332921622374
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,1.05 [0.76-1.44],0.786993149841946
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,44,1.05 [0.98-1.12],0.186413623118193
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,VWF,von Willebrand factor,Inverse variance weighted,8,1.11 [0.78-1.56],0.569830081062778
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.94 [0.67-1.33],0.727291556583804
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL18,Interleukin-18,Inverse variance weighted,42,1.00 [0.90-1.11],0.955821502226605
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFNA1,Ephrin-A1,Inverse variance weighted,15,1.07 [0.90-1.27],0.429148566890445
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,1.00 [0.84-1.19],0.999415263269464
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,1.01 [0.87-1.17],0.868160493766304
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RGMB,RGM domain family member B,Inverse variance weighted,10,1.00 [0.79-1.26],0.992445376071477
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.10 [0.97-1.25],0.12475390153077
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,16,0.86 [0.70-1.06],0.155202481916156
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.96 [0.90-1.03],0.306497919862672
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.81 [0.62-1.06],0.123627609354158
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,29,0.96 [0.81-1.14],0.658924551337875
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EGLN1,Egl nine homolog 1,Inverse variance weighted,4,1.22 [0.85-1.76],0.280765460130534
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,59,1.04 [0.95-1.14],0.408247471938533
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,23,1.07 [0.92-1.24],0.385908662624652
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,45,1.05 [0.94-1.17],0.398566845072224
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.91 [0.70-1.19],0.502462704953602
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,23,1.05 [0.87-1.25],0.629685334394382
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRG2,Bone marrow proteoglycan,Inverse variance weighted,40,0.89 [0.79-1.01],0.0634389042502573
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LY96,Lymphocyte antigen 96,Inverse variance weighted,19,0.93 [0.71-1.23],0.615804054313128
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD27,CD27 antigen,Inverse variance weighted,18,1.00 [0.86-1.16],0.968531652745039
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EFNA4,Ephrin-A4,Inverse variance weighted,5,0.66 [0.44-0.99],0.0421326451434073
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.00 [0.87-1.14],0.980454937938611
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,0.86 [0.68-1.09],0.215242607081912
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,27,1.01 [0.87-1.17],0.94053970833552
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,1.10 [1.01-1.20],0.0288936968742936
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SERPINA11,Serpin A11,Inverse variance weighted,46,1.05 [0.97-1.14],0.21847144518048
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,35,0.98 [0.92-1.03],0.411680170901291
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CNTN5,Contactin-5,Inverse variance weighted,53,1.04 [0.96-1.13],0.315470993409269
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD302,CD302 antigen,Inverse variance weighted,17,0.88 [0.75-1.02],0.0984759522482186
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL17,C-C motif chemokine 17,Inverse variance weighted,35,1.04 [0.95-1.15],0.366424166271992
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,26,1.13 [0.96-1.34],0.146347680159218
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,APOA2,Apolipoprotein A-II,Inverse variance weighted,16,1.07 [0.82-1.39],0.613146262582276
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANG,Angiogenin,Inverse variance weighted,25,0.97 [0.87-1.08],0.523271427817315
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,0.93 [0.74-1.17],0.55869705204697
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CFC1,Cryptic protein,Inverse variance weighted,11,0.87 [0.57-1.32],0.504877836724567
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.99 [0.83-1.18],0.913674501052643
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.05 [0.75-1.47],0.771064303542295
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FOLR1,Folate receptor alpha,Inverse variance weighted,10,1.40 [1.06-1.84],0.01761575075133
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,59,1.01 [0.96-1.06],0.82155590158018
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,39,1.09 [0.96-1.23],0.176007325033128
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,35,1.03 [0.97-1.10],0.323951659045432
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.32 [0.40-4.35],0.652927491390191
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,9,0.85 [0.58-1.24],0.397810068422485
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IFNL1,Interferon lambda-1,Inverse variance weighted,9,1.17 [0.83-1.65],0.361382972260484
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,0.91 [0.80-1.02],0.107839204895715
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.93 [0.78-1.11],0.419769916326993
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.93 [0.69-1.24],0.608579587273005
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD99,CD99 antigen,Inverse variance weighted,4,1.61 [0.94-2.76],0.0855907597812499
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,28,1.03 [0.91-1.18],0.617997315284533
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRTN3,Myeloblastin,Inverse variance weighted,41,0.89 [0.80-0.98],0.0187713955161181
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RSPO1,R-spondin-1,Inverse variance weighted,14,1.09 [0.89-1.33],0.396561996350475
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL15,Interleukin-15,Inverse variance weighted,35,1.03 [0.86-1.24],0.748363917839084
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,36,0.89 [0.81-0.98],0.0175774618883693
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,0.97 [0.87-1.08],0.597413636025119
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DLL1,Delta-like protein 1,Inverse variance weighted,13,0.88 [0.70-1.11],0.281338953795825
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CALB2,Calretinin,Wald ratio,1,0.75 [0.31-1.84],0.532255814319971
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSS,Cathepsin S,Inverse variance weighted,30,1.03 [0.92-1.14],0.645284674831641
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MB,Myoglobin,Inverse variance weighted,10,1.04 [0.73-1.46],0.842809065308785
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,11,1.13 [0.85-1.50],0.388986869012575
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HGF,Hepatocyte growth factor,Inverse variance weighted,7,0.88 [0.59-1.31],0.528292763624238
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRSS8,Prostasin,Inverse variance weighted,19,1.11 [0.85-1.45],0.436559630034863
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,41,1.03 [0.90-1.17],0.70780815682289
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,0.95 [0.79-1.15],0.628180664130339
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEPTIN8,Septin-8,Inverse variance weighted,6,1.41 [1.04-1.91],0.0282561105890179
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.81 [0.52-1.25],0.342986760520178
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,0.83 [0.71-0.96],0.0128494524990903
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.03 [0.92-1.16],0.575277240582215
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,7,1.00 [0.86-1.17],0.996822324287156
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.90 [0.67-1.19],0.451152338299124
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RSPO3,R-spondin-3,Inverse variance weighted,11,0.88 [0.69-1.12],0.288150828609587
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,0.83 [0.56-1.22],0.334521689959799
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASET2,Ribonuclease T2,Inverse variance weighted,25,1.03 [0.89-1.18],0.706680120535907
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL10,Interleukin-10,Inverse variance weighted,5,0.89 [0.72-1.10],0.281042357106559
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ALCAM,CD166 antigen,Inverse variance weighted,11,0.96 [0.76-1.20],0.69550069266693
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GRN,Progranulin,Inverse variance weighted,46,1.08 [0.99-1.19],0.0893216441525505
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.15 [0.86-1.53],0.338179576158229
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,13,1.00 [0.84-1.19],0.993924665255819
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CA6,Carbonic anhydrase 6,Inverse variance weighted,52,1.06 [0.97-1.16],0.221028236685891
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.91 [0.72-1.16],0.450265498595023
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.80 [0.37-1.73],0.566749836359436
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EPO,Erythropoietin,Inverse variance weighted,14,0.79 [0.65-0.97],0.0237219384892296
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.04 [0.86-1.26],0.677060912961842
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLIN3,Perilipin-3,Wald ratio,1,0.69 [0.33-1.47],0.341454440240082
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.02 [0.63-1.65],0.925346559747344
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ITGA5,Integrin alpha-5,Inverse variance weighted,19,1.27 [0.97-1.65],0.0771389255741051
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MDK,Midkine,Inverse variance weighted,19,1.16 [0.93-1.45],0.178777771437583
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,31,0.91 [0.79-1.05],0.209271508445283
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,9,1.00 [0.71-1.42],0.980044680878987
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.88 [0.37-2.10],0.771425381947956
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,24,1.08 [0.93-1.26],0.295691889560506
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.38 [0.13-1.11],0.0759431862768445
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,53,0.93 [0.86-1.01],0.0769341233392142
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.98 [0.88-1.08],0.653906491773397
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,1.05 [0.93-1.19],0.395541859763956
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,74,1.01 [0.96-1.06],0.711355933861402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PGA4,Pepsin A-4,Inverse variance weighted,9,1.10 [0.76-1.58],0.618773823941696
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.61 [0.30-1.24],0.17138590738513
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,4,0.91 [0.67-1.23],0.51990257077571
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,20,0.96 [0.82-1.13],0.627506401243644
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD46,Membrane cofactor protein,Inverse variance weighted,3,1.05 [0.66-1.65],0.841868373479319
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.72 [0.47-1.10],0.126273032623847
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.99 [0.91-1.09],0.874967374571153
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,1.07 [0.69-1.67],0.761092263038799
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,19,1.13 [0.93-1.38],0.225396591267042
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.97 [0.81-1.17],0.758363579623545
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,27,0.99 [0.87-1.12],0.821482740711357
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AGRN,Agrin,Inverse variance weighted,31,0.94 [0.81-1.08],0.364856081205081
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,27,0.97 [0.83-1.14],0.731703829113611
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.03 [0.69-1.54],0.891150565866469
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LCN15,Lipocalin-15,Inverse variance weighted,22,1.03 [0.93-1.14],0.607221359193653
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.03 [0.93-1.13],0.61319347140161
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.07 [0.85-1.34],0.562732527214343
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.65 [1.04-2.60],0.0322735006212716
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.01 [0.84-1.22],0.892639405468045
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.17 [0.80-1.73],0.422212619462398
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,BSG,Basigin,Inverse variance weighted,8,1.11 [0.82-1.49],0.505604269374325
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.81 [0.60-1.09],0.156175345567739
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,1.11 [0.88-1.40],0.37919333159462
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,9,0.84 [0.66-1.06],0.137047239458362
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.97 [0.78-1.20],0.786230852198879
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,0.99 [0.75-1.31],0.932341379110544
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.00 [0.87-1.13],0.946238667395303
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GBP1,Guanylate-binding protein 1,Inverse variance weighted,15,0.95 [0.81-1.11],0.500825034918363
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,27,0.94 [0.88-1.00],0.0659807053948402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.28 [0.96-1.71],0.0935487887245284
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,0.98 [0.90-1.07],0.65559658276484
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ITGA2,Integrin alpha-2,Inverse variance weighted,47,1.04 [0.96-1.12],0.383826213911919
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OGN,Mimecan,Inverse variance weighted,37,0.86 [0.76-0.96],0.0083538343265055
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,1.01 [0.79-1.29],0.934255640504924
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.87 [0.79-0.96],0.0053373244405729
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,2,1.01 [0.53-1.93],0.981404441167222
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,29,1.07 [0.97-1.18],0.1629469028046
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SDC4,Syndecan-4,Inverse variance weighted,37,1.03 [0.88-1.21],0.713357474938707
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,1.04 [0.86-1.25],0.716182873264022
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ITGA11,Integrin alpha-11,Inverse variance weighted,16,1.04 [0.89-1.21],0.657463156522852
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,17,1.19 [1.02-1.39],0.0301566556902642
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.97 [0.57-1.65],0.903561908238059
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.11 [0.90-1.36],0.32110190939049
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,50,0.96 [0.90-1.03],0.224489674682779
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.01 [0.91-1.13],0.802649983590422
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,6,1.29 [0.80-2.09],0.30084328463498
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.02 [0.83-1.25],0.836970770891013
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PENK,Proenkephalin-A,Inverse variance weighted,21,1.08 [0.94-1.24],0.292134523255476
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,19,1.05 [0.86-1.30],0.621793187911281
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.05 [0.70-1.57],0.804735154017651
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.57 [0.34-0.95],0.0302217519573594
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,1.11 [0.97-1.27],0.120344619323598
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,0.35 [0.07-1.85],0.218380666622045
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PSAP,Prosaposin,Inverse variance weighted,13,0.88 [0.74-1.05],0.166006343235178
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.03 [0.89-1.19],0.702482284904364
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDH6,Cadherin-6,Inverse variance weighted,34,0.95 [0.87-1.03],0.235029096660993
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,24,1.27 [0.99-1.63],0.0568718467260106
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.93 [0.78-1.11],0.428302828537723
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PI3,Elafin,Inverse variance weighted,20,0.99 [0.85-1.15],0.891108833261663
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.97 [0.88-1.06],0.485091600574836
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,1.02 [0.84-1.22],0.870209592447141
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL17C,Interleukin-17C,Inverse variance weighted,8,1.08 [0.78-1.49],0.637415806511609
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,29,1.02 [0.86-1.22],0.786199202158929
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,APOC1,Apolipoprotein C-I,Inverse variance weighted,18,0.95 [0.76-1.20],0.677443351418964
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SNCG,Gamma-synuclein,Inverse variance weighted,49,1.04 [0.95-1.13],0.367024713572423
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.05 [0.97-1.13],0.233731281655117
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.82 [0.33-2.02],0.670734964419033
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,0.87 [0.74-1.03],0.102651486364519
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,10,0.89 [0.75-1.05],0.173053182779114
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.91 [0.72-1.16],0.450533207873678
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NUCB2,Nucleobindin-2,Inverse variance weighted,28,1.08 [0.95-1.22],0.26417434597731
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,0.99 [0.84-1.16],0.868829556899528
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,1.05 [0.65-1.71],0.83909513745109
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.13 [0.46-2.78],0.781802307447458
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DSC2,Desmocollin-2,Inverse variance weighted,16,1.03 [0.88-1.22],0.691403136907174
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,11,1.09 [0.85-1.40],0.502871146655169
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,24,1.12 [0.99-1.27],0.0818213829990587
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.02 [0.86-1.22],0.789966365962251
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,0.98 [0.79-1.21],0.836209593806585
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS1,Galectin-1,Inverse variance weighted,7,1.00 [0.85-1.18],0.969924372006579
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MATN2,Matrilin-2,Inverse variance weighted,32,1.02 [0.93-1.12],0.687954486066746
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,1.02 [0.87-1.19],0.833483758242124
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,0.89 [0.82-0.98],0.0122540835552844
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,34,0.94 [0.83-1.07],0.357257950888091
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.04 [0.94-1.15],0.491597309423536
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,14,1.04 [0.85-1.27],0.725404867382582
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.01 [0.43-2.39],0.974417506135544
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CALB1,Calbindin,Inverse variance weighted,11,0.93 [0.69-1.24],0.60678384732608
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS4,Galectin-4,Inverse variance weighted,19,0.95 [0.82-1.10],0.506879520019915
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,1.11 [0.87-1.42],0.38144780350453
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,9,1.37 [1.02-1.84],0.0372004756647143
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.29 [0.88-1.91],0.190525825030784
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,0.96 [0.83-1.11],0.565613744457837
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PVR,Poliovirus receptor,Inverse variance weighted,32,1.02 [0.95-1.10],0.604825248002644
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,0.92 [0.62-1.37],0.678106045835816
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.02 [0.66-1.57],0.927184401262644
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SERPINB8,Serpin B8,Inverse variance weighted,29,0.98 [0.91-1.05],0.571127802868116
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.00 [0.66-1.50],0.984541468242764
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.88 [0.57-1.35],0.550347715929377
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PGF,Placenta growth factor,Inverse variance weighted,8,0.76 [0.41-1.37],0.358385555958247
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,0.98 [0.26-3.67],0.978316440104985
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,EDN1,Endothelin-1,Inverse variance weighted,3,0.99 [0.72-1.35],0.929072906940895
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,27,0.96 [0.80-1.15],0.638930930723888
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.94 [0.66-1.34],0.725826416653722
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL22,Interleukin-22,Inverse variance weighted,5,1.26 [0.71-2.22],0.425577866781777
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,35,0.98 [0.88-1.09],0.751335470894053
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,1.04 [0.95-1.15],0.388157034317061
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRSS2,Trypsin-2,Inverse variance weighted,22,0.80 [0.64-1.00],0.0536089768900168
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD160,CD160 antigen,Inverse variance weighted,36,1.07 [0.95-1.19],0.26049054040623
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCN4,CCN family member 4,Inverse variance weighted,40,1.03 [0.94-1.13],0.577988435309851
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.83 [0.36-1.94],0.669617196067444
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.87 [0.71-1.07],0.178522404754377
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,1.03 [0.89-1.19],0.733647047918109
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSO,Cathepsin O,Inverse variance weighted,22,1.04 [0.88-1.22],0.673262501002946
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANXA10,Annexin A10,Wald ratio,1,4.47 [1.54-13.04],0.0060397972642948
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,2.60 [1.17-5.82],0.0196401587447165
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CTSL,Cathepsin L1,Inverse variance weighted,29,0.97 [0.81-1.16],0.713089897274526
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,16,0.83 [0.63-1.10],0.190592648283007
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.41 [0.71-2.78],0.322979537693306
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,1.13 [0.85-1.50],0.394673687267073
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SLAMF6,SLAM family member 6,Inverse variance weighted,5,1.03 [0.80-1.32],0.844868445249384
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,1.01 [0.90-1.13],0.880994157371585
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,0.99 [0.75-1.30],0.95303561752057
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,0.98 [0.92-1.04],0.441941384369067
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD48,CD48 antigen,Inverse variance weighted,32,0.99 [0.91-1.08],0.887260493143654
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,0.86 [0.70-1.07],0.175964455604402
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SEMA7A,Semaphorin-7A,Inverse variance weighted,25,1.11 [0.90-1.37],0.34357393708162
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,2.82 [0.93-8.53],0.0665672177146061
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,20,1.18 [0.97-1.43],0.106028273013348
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PRELP,Prolargin,Inverse variance weighted,14,1.08 [0.92-1.26],0.35537119823603
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.99 [0.87-1.11],0.813128545995371
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,23,0.99 [0.91-1.08],0.876533723327422
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,1.10 [0.76-1.61],0.614767917378674
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,KLK8,Kallikrein-8,Inverse variance weighted,17,0.88 [0.75-1.02],0.0916673457175139
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.96 [0.56-1.66],0.89163780631506
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL25,C-C motif chemokine 25,Inverse variance weighted,49,1.02 [0.95-1.10],0.533788272551915
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,5,0.97 [0.65-1.45],0.885183177453193
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,0.92 [0.59-1.46],0.734456723331876
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.08 [0.90-1.30],0.415829460042812
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.98 [0.73-1.31],0.876762638233426
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,13,0.87 [0.67-1.12],0.272727829778131
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,1.06 [0.99-1.13],0.0843048095419804
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Inverse variance weighted,5,1.17 [0.81-1.69],0.413661557010636
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.91 [0.63-1.31],0.602953673612456
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CAPG,Macrophage-capping protein,Inverse variance weighted,34,0.96 [0.87-1.06],0.386143213668734
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CST7,Cystatin-F,Inverse variance weighted,81,0.94 [0.86-1.01],0.103971068359287
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,1.45 [0.67-3.16],0.343417345643827
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SPON1,Spondin-1,Inverse variance weighted,25,0.99 [0.87-1.13],0.858459392286006
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,0.64 [0.42-0.98],0.0377952589660491
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,1.04 [0.92-1.17],0.56980249953929
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,OSM,Oncostatin-M,Inverse variance weighted,7,0.75 [0.53-1.06],0.106969757653184
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,33,1.01 [0.87-1.17],0.925928516958909
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PALM,Paralemmin-1,Inverse variance weighted,10,0.97 [0.76-1.23],0.779465994139709
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SDC1,Syndecan-1,Inverse variance weighted,14,1.12 [0.89-1.40],0.328675004500204
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,29,1.06 [0.97-1.16],0.197981479183769
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.74 [0.42-1.31],0.303804510176842
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.97 [0.91-1.04],0.408776747237229
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,13,0.97 [0.84-1.12],0.66914053786367
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.00 [0.87-1.14],0.948563522764133
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,SLAMF8,SLAM family member 8,Inverse variance weighted,28,0.99 [0.94-1.05],0.827701673664539
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,0.96 [0.73-1.28],0.791259578069026
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,1.10 [0.76-1.60],0.599383785210846
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,GSN,Gelsolin,Inverse variance weighted,7,0.63 [0.43-0.92],0.0176421395584855
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,10,1.13 [0.84-1.51],0.417738579038915
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CSTB,Cystatin-B,Inverse variance weighted,25,1.00 [0.88-1.13],0.956111457142335
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CDH2,Cadherin-2,Inverse variance weighted,21,0.89 [0.73-1.10],0.286574980887059
"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,9,0.99 [0.86-1.13],0.875332589879122
